US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Algernon Pharmaceuticals Inc (QB) (AGNPF)
Algernon Pharmaceuticals Inc (QB) (AGNPF) ニュース

AGNPF

Algernon Pharmaceuticals (QB) (AGNPF)

Algernon Pharmaceuticals Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:AGNPF

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/06/03	19 : 03	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/05/09	20 : 41	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/04/25	19 : 05	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/04/15	19 : 34	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/04/07	06 : 28	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/03/24	19 : 08	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2022/02/22	20 : 04	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2021/02/11	22 : 00	InvestorsHub NewsWire	Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2020/06/05	01 : 41	InvestorsHub NewsWire	Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2020/05/28	04 : 14	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2020/04/13	22 : 44	InvestorsHub NewsWire	Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2020/03/13	21 : 40	InvestorsHub NewsWire	Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)
2020/03/06	22 : 32	InvestorsHub NewsWire	Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus	USOTC:AGNPF	Algernon Pharmaceuticals Inc (QB)

Showing the most relevant articles for your search:USOTC:AGNPF

1

Jpm Tb 0-3m Etf

Samsung Heavy Industries

GMO Cyclical Focus Fund ...

Wyoming Oil Minerals

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約